IMUX
Immunic Inc

12,386
Mkt Cap
$76.94M
Volume
1.41M
52W High
$1.45
52W Low
$0.561
PE Ratio
-0.80
IMUX Fundamentals
Price
$0.7799
Prev Close
$0.7891
Open
$0.789
50D MA
$0.8691
Beta
1.47
Avg. Volume
1.52M
EPS (Annual)
-$1.00
P/B
2.27
Rev/Employee
$0.00
Loading...
Loading...
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
91

Frequently Asked Questions

What is Market Cap of Immunic Inc?
What is the 52-week high for Immunic Inc?
What is the 52-week low for Immunic Inc?
What is Immunic Inc stock price today?
What was Immunic Inc stock price yesterday?
What is the PE ratio of Immunic Inc?
What is the Price-to-Book ratio of Immunic Inc?
What is the 50-day moving average of Immunic Inc?
How many employess does Immunic Inc has?

Latest IMUX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.